| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |